NO950684L - Nye imidazopyridinderivater som angiotensin II-antagonister - Google Patents

Nye imidazopyridinderivater som angiotensin II-antagonister

Info

Publication number
NO950684L
NO950684L NO950684A NO950684A NO950684L NO 950684 L NO950684 L NO 950684L NO 950684 A NO950684 A NO 950684A NO 950684 A NO950684 A NO 950684A NO 950684 L NO950684 L NO 950684L
Authority
NO
Norway
Prior art keywords
angiotensin
antagonists
imidazopyridine derivatives
novel imidazopyridine
novel
Prior art date
Application number
NO950684A
Other languages
English (en)
Other versions
NO950684D0 (no
NO304378B1 (no
Inventor
Carmen Almansa
Elena Carceller
Concepcion Gonzalez
Maria Carmen Torres
Javier Bartroli
Original Assignee
Uriach & Cie Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach & Cie Sa J filed Critical Uriach & Cie Sa J
Publication of NO950684D0 publication Critical patent/NO950684D0/no
Publication of NO950684L publication Critical patent/NO950684L/no
Publication of NO304378B1 publication Critical patent/NO304378B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO950684A 1994-02-24 1995-02-23 Nye imidazopyridinderivater som er angiotensin II-antagonister, farmas°ytiske preparater som inneholder dem, og deres anvendelse til fremstilling av medikamenter NO304378B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09400364A ES2079315B1 (es) 1994-02-24 1994-02-24 Nuevas imidazopiridinas.

Publications (3)

Publication Number Publication Date
NO950684D0 NO950684D0 (no) 1995-02-23
NO950684L true NO950684L (no) 1995-08-25
NO304378B1 NO304378B1 (no) 1998-12-07

Family

ID=8285334

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950684A NO304378B1 (no) 1994-02-24 1995-02-23 Nye imidazopyridinderivater som er angiotensin II-antagonister, farmas°ytiske preparater som inneholder dem, og deres anvendelse til fremstilling av medikamenter

Country Status (8)

Country Link
US (1) US5554624A (no)
EP (1) EP0669333A1 (no)
JP (1) JPH07267951A (no)
KR (1) KR950032190A (no)
CA (1) CA2143412A1 (no)
ES (1) ES2079315B1 (no)
MX (1) MX9501084A (no)
NO (1) NO304378B1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DE60022525T2 (de) * 1999-08-30 2006-06-14 Sanofi Aventis Deutschland Ramipril zur vorbeugung von kardiovaskulären vorfällen
WO2005011736A1 (ja) * 2003-07-30 2005-02-10 Tohoku Techno Arch Co., Ltd. アルツハイマー病の予防および／または治療剤
EP1724271A4 (en) * 2004-02-26 2013-01-23 Kyowa Hakko Kirin Co Ltd PREVENTIVE AND / OR THERAPEUTIC AGENT AGAINST NEUTROPHIC INFLAMMATORY DISEASE
JP2008527007A (ja) * 2005-01-14 2008-07-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｒａｆ−キナーゼ阻害活性を有するシンナミドおよびヒドロシンナミド誘導体
US20090291942A1 (en) * 2008-05-26 2009-11-26 Ivan Cornella Taracido Imidazo pyridine derivatives
WO2011138657A1 (en) * 2010-05-04 2011-11-10 Glenmark Pharmaceuticals S.A. Aryl substituted olefinic compounds as pde10a inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5240938A (en) * 1991-02-13 1993-08-31 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring
CA2075637A1 (en) * 1990-02-13 1991-08-14 William J. Greenlee Angiotensin ii antagonists incorporating a substituted benzyl element
DE4142366A1 (de) * 1991-07-15 1993-06-24 Thomae Gmbh Dr K Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES2079315A1 (es) 1996-01-01
MX9501084A (es) 1997-10-31
JPH07267951A (ja) 1995-10-17
NO950684D0 (no) 1995-02-23
KR950032190A (ko) 1995-12-20
NO304378B1 (no) 1998-12-07
CA2143412A1 (en) 1995-08-25
EP0669333A1 (en) 1995-08-30
ES2079315B1 (es) 1996-10-16
US5554624A (en) 1996-09-10

Similar Documents

Publication Publication Date Title
DK0569013T3 (da) Quinolinforbindelser som angiotensin II antagonister
FI964712A0 (fi) Kinoliinijohdannaisia takykiniini NK3-reseptoriantagonisteina
ATE236155T1 (de) Naphthyridin-derivate
NO20020814D0 (no) Nye spiroforbindelser
NO983356L (no) Nye 19-nor-pregnenderivater
DK0533268T3 (da) Benzanilidderivater som 5HT-1D antagonister
DK0901470T3 (da) Indolderivater egnede som endothelinreceptorantagonister
DK0885215T3 (da) Nye benzo-1,3-dioxolyl- og benzofuranyl-substituerede pyrrolidinderivater som endthelinantagonister
DK0922034T3 (da) Tetrahydroquinolinderivater som EAA-antagonister
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
NO991384D0 (no) Substituerte heterocykler som anti-tumormidler
NO974043D0 (no) Indolderivater som EAA-antagonister
DE69706823T2 (de) Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren
NO985684D0 (no) 1,3,8-Triaza-spiro(4,5)dekan-4-on-derivater
NO962717D0 (no) Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO961333D0 (no) Nye pyrazolderivater som angiotensin-II-antagonister
NO20002439L (no) Nye orale doseringsformer for carvediol
NO950684L (no) Nye imidazopyridinderivater som angiotensin II-antagonister
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO992066D0 (no) Piperazinoderivater som neurokininantagonister
NO985972D0 (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002